Early evidence suggested that IL-18 has anticancer effect on tumour, which stimulated the cytotoxicity of natural killer cells (NKs) and enhanced the immune response of CD8+T lymphocytes (CD8+T) [20]. This evidence concerns the gene IL18 and neoplasm.